Henry Ji
Sachigaro, Mutungamiri uye CEO
- 25+ makore echiitiko muiyo biotechnology uye hupenyu sainzi indasitiri
- Dr. Ji vakavamba Sorrento uye vakashanda semutungamiriri kubva 2006, CEO uye Mutungamiri kubva 2012, uye Sachigaro kubvira 2017.
- Munguva yekutonga kwake kuSorrento, akagadzira uye akatungamira kukura kunoshamisa kweSorrento kuburikidza nekutora uye kubatanidzwa kunosanganisira Bioserv, Scilex Pharmaceuticals, Concortis Biotherapeutics, Levena Biopharma, LACEL, TNK Therapeutics, Virttu Biologics, Ark Animal Health, uye Deliverysa Systems Lymphatic.
- Akashanda seSorrento's Chief Scientific Officer kubva 2008 kusvika 2012 uye seInterim CEO kubva 2011 kusvika 2012.
- Asati asvika Sorrento, akabata zvinzvimbo zvepamusoro kuCombiMatrix, Stratagene uye zvakare akavamba Stratagene Genomics, mubatsiri weStratagene, uye akashanda seMutungamiri & CEO uye Director weBhodi.
- BS uye Ph.D.
Kuvhara X
Dorman Followwill
Director
- VaFollowwill, vakashanda semutungamiriri kubva munaGunyana 2017
- Anga ari Senior Partner, Shanduko Hutano kuFrost & Sullivan, bhizinesi rekubvunza femu inobatanidzwa mukutsvaga kwemusika uye kuongorora, kukura zano rekubvunza uye kudzidziswa kwemakambani mumaindasitiri akawanda, kubvira 2016.
- Nguva iyoyo isati yasvika, akashanda mumabasa akasiyana-siyana kuFrost & Sullivan, kusanganisira Partner pane Executive Committee inotarisira P & L yebhizimisi muEurope, Israel neAfrica, uye Partner anotarisira bhizinesi reHealthcare uye Life Sciences muNorth America, kubvira pakutanga kujoinha. Frost & Sullivan kuti vabatsire kuwana iyo Consulting tsika muna Ndira 1988
- VaFollowwill vane makore anopfuura makumi matatu ehutungamiriri hwesangano uye ruzivo rwehutungamiriri, vashanda mumazana emapurojekiti ekupa mazano munzvimbo dzese dzakakura uye nematunhu mazhinji emaindasitiri, chirongwa chega chega chakatarisana nehurongwa hwekukura.
- BA
Kuvhara X
Kim D. Janda
Director
- Dr. Janda vakashanda semutungamiriri kubva muna Kubvumbi 2012
- Dr. Janda ave ari Ely R. Callaway, Jr. Sachigaro Purofesa muDhipatimendi reChemistry, Immunology uye Microbial Science paThe Scripps Research Institute ("TSRI") kubvira 1996 uye seMutungamiri weWorm Institute of Research and Medicine ( “WIRM”) kuTSRI kubvira 2005. Uyezve, Dr. Janda akashanda seSkaggs Scholar mukati meSkaggs Institute of Chemical Biology, zvakare kuTSRI, kubvira 1996.
- Akadhinda mabhuku ekutanga anodarika mazana mana nemakumi maviri nemashanu mumagazini anotariswa nevezera rake uye akatanga makambani ebiotechnological CombiChem, Drug Abuse Sciences uye AIPartia Dr. Janda ishamwari mupepeti we “Bioorganic & Medicinal Chemistry”, “PLoS ONE” uye anoshanda, kana kuti akamboshanda. , pamapuranga ezvinyorwa zvemagazini akawanda kusanganisira J. Comb. Chem., Chem. Wongororo, J. Med. Chem., Iyo Botulinum Journal, Bioorg. & Med. Chem. Lett., uye Bioorg. & Med. Chem
- Kwemakore anopfuura makumi maviri nemashanu, Dr. Janda vakapa zvipo zvakawanda uye vanoonekwa semumwe wemasayendisiti ekutanga kubatanidza nzira dzemakemikari nebhayoloji kuita chirongwa chakabatana chekutsvagisa.
- Dr. Janda vakashanda paScientific Advisory Boards yeMateria neSingapore Ministry of Education
- BS uye Ph.D.
Kuvhara X
David Lemus
Director
- VaLemus vakashanda semukuru weKambani kubva muna Gunyana 2017
- Parizvino ndiye CEO weIronshore Pharmaceuticals, Inc.
- Pamusoro pezvo anoshanda senhengo isiri-executive board yeSilence Therapeutics (NASDAQ: SLN) uye BioHealth Innovation, Inc.
- Kare kuSigma Tau Pharmaceuticals, Inc. kubva 2011-2015, akashanda seCEO.
- Pamusoro pazvo VaLemus vakashanda seCFO uye Executive VP weMorphoSys AG kubva 1998-2011, vachitora kambani kuruzhinji muGermany yekutanga biotech IPO.
- Asati aita basa kuMorphoSys AG, akabata zvinzvimbo zvakasiyana-siyana zvekutonga zvinosanganisira makambani Hoffman La Roche, Electrolux AB, uye Lindt & Spruengli AG (Group Treasurer)
- BS, MS, MBA, CPA
Kuvhara X
Jaisim Shah
Director
- VaShah vakashanda semutungamiriri kubva muna 2013
- 25+ makore ane ruzivo muindasitiri yemishonga
- VaShah parizvino vari kushanda seMukuru Mukuru uye Mutungamiriri weScilex Holding neScilex Pharmaceutical.
- Asati asvika Scilex, akashanda seMutungamiriri weSemnur Pharmaceuticals (yakawanikwa neScilex Pharmaceuticals) kubva payakavambwa muna 2013.
- Kubva 2011 kusvika 2012, akashanda seMukuru Bhizinesi Mukuru weElevation Pharmaceuticals uko aitarisa mari, kubatanidza uye kutora, uye kusimudzira bhizinesi.
- Vasati vasvika Kukwidziridzwa, VaShah vaive Mutungamiriri weZelos Therapeutics, kwavaitarisa mari nekusimudzira bhizinesi.
- Pamberi paZelos, VaShah vaive Mutevedzeri weMutungamiriri Mukuru uye Chief Business Officer kuCytRx. Pakutanga, VaShah vaive Chief Business Officer kuFacet Biotech uye PDL BioPharma kwavakapedza akawanda marezinesi / kudyidzana uye kutengeserana kwehunyanzvi.
- PDL isati yasvika, VaShah vaive VP weGlobal Marketing kuBMS kwavakagashira “Presidents Award” yekupedza kumwe kwekudyidzana kwakakosha munhoroondo yekambani.
- MA uye MBA
Kuvhara X
Yue Alexander Wu
Director
- Dr. Wu akashanda semutungamiriri kubva Nyamavhuvhu 2016
- Parizvino anoshandawo paBOD yeScilex Pharmaceutical kubvira 2019
- Dr. Wu vaive muvambi, CEO, Mutungamiriri, uye Chief Scientific Officer weCrown Bioscience International, kambani inotungamira yepasi rose yekuwanikwa kwezvinodhaka nekuvandudza mhinduro, yaakavamba mu2006.
- Kubva 2004 kusvika 2006, aive Chief Business Officer weStarvax International Inc. muBeijing, China, kambani yebiotechnology yakatarisana neoncology nezvirwere zvinotapukira.
- Kubva 2001 kusvika 2004, aive mubhangi neBurrill & Company kwaaive mukuru weAsia Activities.
- BS, MS, MBA, uye Ph.D.
Kuvhara X